Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Colman

Showing results (311-320 of 466) with videos related to

Pageof 47
Sort By:
The New England Journal of Medicine|September 24, 1970
A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseasesD P Thomas, S Niewiarowski, A R Myers, et al.
Blood|June 1, 1979
Effects of prostacyclin and albumin on platelet loss during in vitro simulation of extracorporeal circulationV P Addonizio, J Macarak, K C Nicolaou, et al.
Blood|April 1, 1988
Mechanism of transient adsorption of fibrinogen from plasma to solid surfaces: role of the contact and fibrinolytic systemsJ L Brash, C F Scott, P ten Hove, et al.
Investigative Ophthalmology|September 1, 1973
Platelet-induced vitreous membrane formationI J Constable, M Oguri, C M Chesney, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Inhibition of thrombin-induced platelet aggregation by high molecular weight kininogenR W Colman, R N Puri, E J Gustafson, et al.
The American Journal of Pathology|January 1, 1976
Hyperacute renal allograft rejection in the primate. Therapeutic limitations of antiplatelet agents alone and combined with heparinR W Colman, M Habal, N K Hollenberg, et al.
Blood|February 1, 1991
High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to plateletsR N Puri, F Zhou, C J Hu, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1977
Preservation of platelets during extracorporeal circulation with prostaglandin E1V P Addonizio, E J Macarak, S Niewiarowski, et al.
The Journal of Clinical Investigation|June 1, 1984
Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitorA de Agostini, H R Lijnen, R A Pixley, et al.
Chest|May 1, 1973
Pulmonary hemorrhage syndrome as a manifestation of disseminated intravascular coagulation: analysis of ten casesS J Robboy, J D Minna, R W Colman, et al.
Pageof 47

Showing results (311-320 of 466) with videos related to

Sort By:
Pageof 47
The New England Journal of Medicine|September 24, 1970
A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseasesD P Thomas, S Niewiarowski, A R Myers, et al.
Blood|June 1, 1979
Effects of prostacyclin and albumin on platelet loss during in vitro simulation of extracorporeal circulationV P Addonizio, J Macarak, K C Nicolaou, et al.
Blood|April 1, 1988
Mechanism of transient adsorption of fibrinogen from plasma to solid surfaces: role of the contact and fibrinolytic systemsJ L Brash, C F Scott, P ten Hove, et al.
Investigative Ophthalmology|September 1, 1973
Platelet-induced vitreous membrane formationI J Constable, M Oguri, C M Chesney, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Inhibition of thrombin-induced platelet aggregation by high molecular weight kininogenR W Colman, R N Puri, E J Gustafson, et al.
The American Journal of Pathology|January 1, 1976
Hyperacute renal allograft rejection in the primate. Therapeutic limitations of antiplatelet agents alone and combined with heparinR W Colman, M Habal, N K Hollenberg, et al.
Blood|February 1, 1991
High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to plateletsR N Puri, F Zhou, C J Hu, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1977
Preservation of platelets during extracorporeal circulation with prostaglandin E1V P Addonizio, E J Macarak, S Niewiarowski, et al.
The Journal of Clinical Investigation|June 1, 1984
Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitorA de Agostini, H R Lijnen, R A Pixley, et al.
Chest|May 1, 1973
Pulmonary hemorrhage syndrome as a manifestation of disseminated intravascular coagulation: analysis of ten casesS J Robboy, J D Minna, R W Colman, et al.
Pageof 47